Cor et Vasa, 2010 (vol. 52), issue 1-2

Editorial

Česká arytmologie v roce 2009 - úvodní slovo předsedy PSAKS ČKS

Josef Kautzner

Cor Vasa 2010, 52(1-2):7-8  

Review articles

Telemedicine - a discovery of the third millennium?

Ondřej Ošmera, Alan Bulava

Cor Vasa 2010, 52(1-2):55-61 | DOI: 10.33678/cor.2010.011  

Telemedicine (telematics for healthcare) provides health care services, activities and systems from one place to another using modern communication technologies. It is a dynamic sphere with a substantial growth in clinical and theoretical applications in chronic disease management. Telemonitoring is the distant evaluation of one's health status. Systems for telemonitoring of patients with implantable cardioverter-defibrillators and cardiac-resynchronisation therapy are broadly used in cardiology. The most advanced is Home Monitoring by BIOTRONIK and it is the only one currently used in the Czech Republic. A number of studies have proved its safety...

Cardiac device-related infection - a new epidemic?

Jitka Vlašínová

Cor Vasa 2010, 52(1-2):62-66 | DOI: 10.33678/cor.2010.012  

Despite recent major advances in medicine we are now faced with a relatively new group of patients with cardiac device-related infection. It is necessary to pay close attention to the increasing number of these patients, to identification of the risk factors which predispose to this complication as well as to their specific identification treatment which has its specifics. The aim of this article is to offer an overview of problems experienced by patients with cardiac device-related infection.

Commentary

Komentář k přehodnocení evropských doporučení léčby arteriální hypertenze

Prof. MUDr. Jiří Widimský jr., CSc.

Cor Vasa 2010, 52(1-2):75-78  

Case reports

Is catheter ablation for atrial fibrillation superior to pharmacotherapy?

Alan Bulava

Cor Vasa 2010, 52(1-2):9-16 | DOI: 10.33678/cor.2010.003  

Atrial fibrillation is the most common supraventricular arrhythmia. The incidence of atrial fibrillation in overall population reaches 5% according to some recent estimates. Based on these data, atrial fibrillation together with congestive heart failure is considered to be one of the 21st century epidemics. The presence of this arrhythmia doubles overall mortality and, due to predisposition to thrombus formation, it is responsible for more than one third of embolisation episodes, with a non-negligible socioeconomic impact. Antiarrhythmic therapy for atrial fibrillation is a most challenging issue. Novel non-pharmacological technologies for arrhythmia...

Catheter ablation of ventricular tachycardias: review of literature and own experience

Petr Peichl, Josef Kautzner

Cor Vasa 2010, 52(1-2):17-24 | DOI: 10.33678/cor.2010.004  

Catheter ablation of ventricular tachyarrhythmias (VTs) has undergone remarkable development during the last decade. In the majority of patients with idiopathic VTs, catheter ablation represents curative therapy without the necessity of any additional pharmacotherapy. In contrast, in patients with severe systolic dysfunction or rapid VTs, implantation of a cardioverter-defibrillator remains the treatment of choice due to the high risk of sudden cardiac death. Catheter ablation is then indicated in those with recurrent arrhythmias and device discharges. In case of arrhythmic storm, the ablation may represent life-saving therapy.

Robotic navigation for catheter ablation of atrial fibrillation

Josef Kautzner, Petr Peichl, Peter Hlivák, Robert Čihák

Cor Vasa 2010, 52(1-2):25-29 | DOI: 10.33678/cor.2010.005  

Catheter ablation of atrial fibrillation (AF) is associated with many technical challenges such as difficult orientation in the left atrium due to significant variability in the arrangement of pulmonary veins, problems with contact between the tip of the ablation catheter and tissue, and increased radiation dose. Two remote control systems have been introduced into clinical practice to overcome these challenges. One of them - an electromechanical navigation system - has already been used in many centres as a standard method. Current experience suggests that this method has many advantages. It allows a standardized ablation procedure, limits fatigue...

Infection of the aorta and great arteries by Salmonella enteritidis

Jiří Moláček, Karel Houdek, Jan Baxa, Bohuslav Čertík, Vladislav Třeška

Cor Vasa 2010, 52(1-2):67-70 | DOI: 10.33678/cor.2010.013  

While, in some rare cases, aneurysms of the abdominal aorta or another great artery may be caused by an infectious agent, in other cases, secondary infection may develop in a preexisting aneurysm or even in a non-dilated artery (most often, the aorta or a branch thereof). These cases are invariably very serious and life-threatening. A typical infectious agent with particular affinity to the abdominal aorta is Salmonella enteritidis. The authors present three case reports with the aorta or another great artery infected by this particular Gram-negative bacterium. They discuss the pitfalls of these rare conditions, their diagnosis and, most importantly,...

Reviews

Josef Veselka, Kateřina Linhartová, David Zemánek, et al.: Kardiomyopatie

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2010, 52(1-2):95  

Martin Riedel: Dějiny kardiologie

Prof. MUDr. Jan Petrášek, DrSc., Mgr. Jaroslav Hořejší

Cor Vasa 2010, 52(1-2):96-97  

Images in cardiology

Hepatocelulární karcinom prorůstající do pravé srdeční síně

Martin Mašek, Manuela Vaněčková

Cor Vasa 2010, 52(1-2):71-72 | DOI: 10.33678/cor.2010.014  

Kardiální manifestace myeloproliferativního onemocnění s eosinofilií

Ludmila Nováková, Dana Mikulenková, Tomáš Paleček

Cor Vasa 2010, 52(1-2):73-74 | DOI: 10.33678/cor.2010.015  

Reports

Informace ze semináře Ministerstva zdravotnictví ČR. Co se skrývá pod zkratkou MKF?

MUDr. Jiří Leso

Cor Vasa 2010, 52(1-2):94 | DOI: 10.33678/cor.2010.025  

News

Zápis ze schůze výboru Pracovní skupiny ošetřovatelství v kardiologii ČKS, konané dne 9. ledna 2010

Mgr. Ludmila Klemsová, MUDr. Jiří Leso

Cor Vasa 2010, 52(1-2):98-99  

Abstracts

12. symposium pracovní skupiny Chlopenní a vrozené srdeční vady v dospělosti České kardiologické společnosti

Cor Vasa 2010, 52(1-2):100-101  

12. symposium Pracovní skupiny chlopenní a vrozené srdeční vady v dospělosti České kardiologické společnosti

Cor Vasa 2010, 52(1-2):102-106  

Cardiology nurses section

Střípky z listopadové konference kardiologických sester

Jiří Leso

Cor Vasa 2010, 52(1-2):84  

Řešení cévní mozkové příhody v přednemocniční neodkladné péči - úkoly sestry, kasuistika

Jitka Callerová, Roman Škulec

Cor Vasa 2010, 52(1-2):84-86  

Časné vyjmutí zavaděče z arteria femoralis registrovanými sestrami po diagnostické koronarografii

Ludmila Klemsová, Eva Zvolánková, Jana Zarembová, Marcela Olšová, Renata Pavelková

Cor Vasa 2010, 52(1-2):86-88  

První zkušenosti s ošetřováním pacienta po transplantaci srdce a plic - kasuistika

Anna Nechvílová

Cor Vasa 2010, 52(1-2):88-90  

Adresář výboru Pracovní skupiny ošetřovatelství v kardiologii ČKS 2009-2012

Cor Vasa 2010, 52(1-2):90  

On a single topic

Primary prevention of sudden cardiac death - ICDs for every patient with ventricular dysfunction?

Lubomír Křivan

Cor Vasa 2010, 52(1-2):30-35 | DOI: 10.33678/cor.2010.006  

Despite advances in the diagnosis and treatment of cardiac diseases, sudden cardiac death remains a most topical problem. Implantable cardioverter-defibrillators (ICDs) have been used in sudden cardiac death prevention for almost three decades. A major breakthrough has occurred over the last ten years. The number of secondary prevention ICD implantations has remained nearly stable whereas that of primary prevention ICD recipients has increased. As the number of ICD-indicated patients increases, ICD efficacy declines and costs rise dramatically. The objective of this paper is to put the guidelines for primary prevention ICD implantation into context...

Indications for ICD implantation in the primary prevention of sudden cardiac death after a STEMI. The impact of a change in the Czech Society of Cardiology guidelines on the number of patients scheduled for the procedure

Rostislav Polášek, Pavel Nedbal, Lukáš Jaworski, Pavel Kučera, Klára Skoupá, Jana Hanuliaková, David Horák

Cor Vasa 2010, 52(1-2):36-38 | DOI: 10.33678/cor.2010.007  

Aim: The aim of this original contribution was to compare the number of patients scheduled for primary preventive ICD implantation according to the old (2005) and new (2009) Guidelines of the Czech Society of Cardiology in patients after ST-segment elevation myocardial infarction (STEMI).Methods and results: We examined 205 consecutive patients 12-29 months after STEMI. We took their history, and ECHO and ECG were performed. No electrophysiology study was performed. Based on these examinations, we assessed the indication for ICD implantation in the primary prevention of sudden cardiac death according to the old and new guidelines. A total of 310...

Clinical characteristics of three Czech families with catecholaminergic polymorphic ventricular tachycardia and pilot results of RyR2 gene mutation analysis

Tomáš Novotný, Peter Kubuš, Pavel Vít, Alena Floriánová, Irena Dohnalová, Iveta Valášková, Jitka Kadlecová, Renata Gaillyová, Eva Švandová, Jindřich Špinar

Cor Vasa 2010, 52(1-2):39-42 | DOI: 10.33678/cor.2010.008  

Aim: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare hereditary arrhythmia. The onset of clinical symptoms usually occurs during childhood, and is typically related to stress. The aim of our study is to provide clinical characteristics of three Czech families with CPVT and pilot results of mutation analysis of the RyR2 gene.Methods: The subjects and their relatives are investigated at the participating departments. They undergo basic clinical investigation, with their history-taking focused on possible CPVT symptoms, i.e. syncopes during stress. Bicycle ergometry is performed to obtain ECG recordings during adrenergic stimulation....

The importance of ventricular dyssynchrony in predicting the response to cardiac resynchronization therapy

Rudolf Praus, Miloslav Tauchman, Luděk Haman, Václav Bláha, Petr Pařízek

Cor Vasa 2010, 52(1-2):43-48 | DOI: 10.33678/cor.2010.009  

Aim: The aims of this prospective study were to define the numbers of responders and non-responders to cardiac resynchronization therapy (CRT) and differences between these groups, and to assess the development of clinical and echocardiographic effects of CRT in the group of responders over a period of time.Group of patients and methods: A total of 58 patients with a biventricular system implanted from July 2005 through May 2008 were included into the follow-up. The mean age of patients was 67 ± 9 years; they were classified in NYHA Class IV (one patient), III-IV (18 patients), III (23 patients), and II (three patients), with average QRS...

Optimal localization of the electric lead system in cardiac resynchronization therapy

Kamil Sedláček, Vlastimil Vančura, Ivo Skalský, Tomáš Martinča, Robert Čihák, Jan Bytešník, Josef Kautzner

Cor Vasa 2010, 52(1-2):49-54 | DOI: 10.33678/cor.2010.010  

Cardiac resynchronization therapy has become an integral part of management of patients with advanced chronic heart failure and cardiac dyssynchrony defined by QRS complex widening in the guidelines. Conceptually, the method is based on mechanical resynchronization of asynchronous, antrioventricular, interventricular, and left intraventricular contractions. A major determinant of resynchronization therapy outcome is the position of individual leads, specifically the left ventricular, right ventricular and, theoretically, also the atrial leads. The review addresses various aspects of identifying the optimal position for individual leads as well as possibilities...

Reflections

Kardiologie a dědictví Pierra de Coubertina

Cor Vasa 2010, 52(1-2):80-81  

Personalia

Prof. MUDr. Bohuslav Ošťádal, DrSc., se dožívá 70 let

Jiří Widimský, Michael Aschermann

Cor Vasa 2010, 52(1-2):82-83  

Contents

Úvodní slovo, Děkujeme recenzentům

Michael Aschermann, Vladimír Staněk

Cor Vasa 2010, 52(1-2):6  

Informations

Top ten v kardiologii 2009

Mgr. Jaroslav Hořejší

Cor Vasa 2010, 52(1-2):91-93  


Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.